There are often no noticeable symptoms, but some patients may only have a heart murmur, a "swishing noise" doctors can hear ...
At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...
In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...
Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...
7d
News-Medical.Net on MSNHeart failure patients benefit from dapagliflozin after TAVR procedurePatients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...
The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results